Abstract
Chronic lung disease is a complication of primary antibody deficiency (PAD) associated with significant morbidity and mortality. Manifestations of lung disease in PAD are numerous. Thoughtful application of diagnostic approaches is imperative to accurately identify the form of disease. Much of the treatment used is adapted from immunocompetent populations. Recent genomic and translational medicine advances have led to specific treatments. As chronic lung disease has continued to affect patients with PAD, we hope that continued advancements in our understanding of pulmonary pathology will ultimately lead to effective methods that alleviate impact on quality of life and survival.
| Original language | English |
|---|---|
| Pages (from-to) | 437-459 |
| Number of pages | 23 |
| Journal | Immunology and Allergy Clinics of North America |
| Volume | 40 |
| Issue number | 3 |
| DOIs | |
| State | Published - Aug 2020 |
| Externally published | Yes |
Keywords
- Asthma
- Bronchiectasis
- Common variable immunodeficiency
- GLILD
- Interstitial lung disease
- Lung disease
- Primary antibody deficiency
Fingerprint
Dive into the research topics of 'Chronic Lung Disease in Primary Antibody Deficiency: Diagnosis and Management'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver